GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,254 | -31.5% | 7,454,703 | -0.5% | 0.00% | -33.3% |
| Q2 2023 | $41,219 | +25.4% | 7,494,184 | -2.0% | 0.01% | +20.0% |
| Q1 2023 | $32,871 | +15.2% | 7,644,195 | +5.3% | 0.01% | 0.0% |
| Q4 2022 | $28,536 | -99.9% | 7,261,046 | -1.8% | 0.01% | -16.7% |
| Q3 2022 | $39,272,000 | -33.0% | 7,395,573 | -17.2% | 0.01% | -14.3% |
| Q2 2022 | $58,591,000 | -8.9% | 8,931,613 | +1.9% | 0.01% | +16.7% |
| Q1 2022 | $64,325,000 | +5.1% | 8,763,691 | +1.3% | 0.01% | 0.0% |
| Q4 2021 | $61,222,000 | -71.7% | 8,647,121 | +0.2% | 0.01% | -70.0% |
| Q3 2021 | $216,309,000 | +9.2% | 8,628,216 | +17.2% | 0.02% | +11.1% |
| Q2 2021 | $198,068,000 | +7.3% | 7,363,115 | +13.5% | 0.02% | 0.0% |
| Q1 2021 | $184,550,000 | +48.1% | 6,484,544 | +47.6% | 0.02% | +38.5% |
| Q4 2020 | $124,575,000 | -3.3% | 4,394,184 | +1.7% | 0.01% | -13.3% |
| Q3 2020 | $128,866,000 | +52.3% | 4,320,962 | +3.3% | 0.02% | +36.4% |
| Q2 2020 | $84,615,000 | – | 4,181,178 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |